(Q37057309)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

New developments in understanding and treating neuroinflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Frauke Zipp

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

C Infante-Duarte

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

J Wuerfel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

15 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

975-985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18196212%20AND%20SRC:MED&resulttype=core&format=json

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Green tea in chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Green tea and cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Atorvastatin induces T cell anergy via phosphorylation of ERK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Geranylgeranylation but not GTP loading determines rho migratory function in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0292-0

Lysophospholipid receptors: signaling and biology

21 January 2018

1 reference

12 December 2020

Multiphoton microscopy in biological research.

1 reference

12 December 2020

Neuronal damage in brain inflammation

1 reference

12 December 2020

Infectious causes of multiple sclerosis

1 reference

12 December 2020

Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions

1 reference

12 December 2020

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

1 reference

12 December 2020

Two-photon laser scanning fluorescence microscopy

1 reference

12 December 2020

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

1 reference

12 December 2020

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

1 reference

12 December 2020

Blood-brain barrier disruption in multiple sclerosis

1 reference

12 December 2020

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

1 reference

12 December 2020

What do we know about the mechanism of action of disease-modifying treatments in MS?

1 reference

12 December 2020

CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology.

1 reference

12 December 2020

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

12 December 2020

What went wrong in the natalizumab trials?

1 reference

12 December 2020

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

1 reference

12 December 2020

Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate

1 reference

12 December 2020

Assessment of nerve degeneration by gadofluorine M-enhanced magnetic resonance imaging

1 reference

12 December 2020

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

12 December 2020

Impact of HMG-CoA reductase inhibition on brain pathology

1 reference

12 December 2020

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

1 reference

12 December 2020

Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage

1 reference

12 December 2020

Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea.

1 reference

12 December 2020

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

1 reference

12 December 2020

The role of nitric oxide in multiple sclerosis

1 reference

12 December 2020

Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice

1 reference

12 December 2020

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

1 reference

12 December 2020

Blockade of chemokine signaling in patients with multiple sclerosis

1 reference

12 December 2020

Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years

1 reference

12 December 2020

Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench

1 reference

12 December 2020

Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival.

1 reference

12 December 2020

Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols

1 reference

12 December 2020

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

1 reference

12 December 2020

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

1 reference

12 December 2020

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

12 December 2020

The gene specifying RNase E (rne) and a gene affecting mRNA stability (ams) are the same gene

1 reference

12 December 2020

Drug discovery: playing dirty

1 reference

12 December 2020

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis

1 reference

12 December 2020

HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis

1 reference

12 December 2020

Basic principles of immunological surveillance of the normal central nervous system

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

1 reference

12 December 2020

Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils

1 reference

12 December 2020

Therapeutic potential of lovastatin in multiple sclerosis.

1 reference

12 December 2020

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

12 December 2020

Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice

1 reference

12 December 2020

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time

1 reference

12 December 2020

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

1 reference

12 December 2020

Grey Matter Pathology in Multiple Sclerosis

1 reference

12 December 2020

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis

1 reference

12 December 2020

Mouse model mimics multiple sclerosis in the clinico-radiological paradox

1 reference

12 December 2020

The contribution of demyelination to axonal loss in multiple sclerosis

1 reference

12 December 2020

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

1 reference

12 December 2020

Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease

1 reference

12 December 2020

Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.

1 reference

12 December 2020

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

12 December 2020

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

1 reference

12 December 2020

Focal thinning of the cerebral cortex in multiple sclerosis

1 reference

12 December 2020

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

12 December 2020

CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons

1 reference

12 December 2020

High-field diffusion tensor imaging of mouse brain in vivo using single-shot STEAM MRI.

1 reference

12 December 2020

Immune-mediated neurodegeneration and neuroprotection in MS.

1 reference

12 December 2020

Clinical application of high and ultra high-field MRI.

1 reference

12 December 2020

In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity

1 reference

12 December 2020

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

1 reference

12 December 2020

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

12 December 2020

Stroke-induced immunodepression: experimental evidence and clinical relevance

1 reference

12 December 2020

Imaging input and output of neocortical networks in vivo

1 reference

12 December 2020

TRAIL limits excessive host immune responses in bacterial meningitis

1 reference

12 December 2020

Environmental risk factors in multiple sclerosis aetiology

1 reference

12 December 2020

Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum.

1 reference

12 December 2020

Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity

1 reference

12 December 2020

Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration

1 reference

12 December 2020

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

12 December 2020

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis

1 reference

12 December 2020

Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells

1 reference

12 December 2020

Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

1 reference

12 December 2020

Technology insight: in vivo cell tracking by use of MRI.

1 reference

12 December 2020

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

1 reference

12 December 2020

Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.

1 reference

12 December 2020

Mitochondria take center stage in aging and neurodegeneration

1 reference

12 December 2020

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets

1 reference

12 December 2020

Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease

1 reference

12 December 2020

Nitric oxide, cell bioenergetics and neurodegeneration.

1 reference

12 December 2020

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

1 reference

12 December 2020

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

12 December 2020

Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease.

1 reference

12 December 2020

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

12 December 2020

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

1 reference

12 December 2020

Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue.

1 reference

12 December 2020

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro

1 reference

12 December 2020

Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes.

1 reference

12 December 2020

In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis.

1 reference

12 December 2020

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Epidemiology and natural history of multiple sclerosis: new insights

1 reference

12 December 2020

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

1 reference

12 December 2020

Axonal damage in acute multiple sclerosis lesions.

1 reference

12 December 2020

A miniature head-mounted two-photon microscope. high-resolution brain imaging in freely moving animals

1 reference

12 December 2020

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

1 reference

12 December 2020

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

1 reference

12 December 2020

Interleukin-1 and neuronal injury

1 reference

12 December 2020

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

1 reference

12 December 2020

Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration

1 reference

12 December 2020

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

1 reference

12 December 2020

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

1 reference

12 December 2020

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

1 reference

12 December 2020

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

1 reference

12 December 2020

Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion.

1 reference

12 December 2020

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1 reference

12 December 2020

Cortical lesions in multiple sclerosis

1 reference

12 December 2020

Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration.

1 reference

12 December 2020

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

12 December 2020

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

1 reference

12 December 2020

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

12 December 2020

A controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

12 December 2020

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

1 reference

12 December 2020

Tea and Cancer Prevention: Studies in Animals and Humans

1 reference

12 December 2020

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

1 reference

12 December 2020

Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins

1 reference

12 December 2020

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis

1 reference

12 December 2020

Über Elementarakte mit zwei Quantensprüngen

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1002/ANDP.19314010303